Pollogen launches the TriLipo MED anti-aging procedure at the upcoming European Academy of Dermatology and Venerology (EADV)

Share Article

Clinical evidence confirming the benefits of the TriLipo MED procedure for anti-aging facial treatment as well as body contouring and cellulite reduction will be presented by G. Buendía, M.D. and A. Levenberg, M.D. during the upcoming EADV conference. A technological breakthrough, TriLipo MED allows for treatment of 4 layers of skin tissue, using 3 advanced technologies all within a single system.

4.6 cm reduction in treated thigh

4.6 cm reduction in treated thigh

Amichai-Bar Nir, Pollogen is dedicated to delivering genuine innovation. The introduction of the TriLipo MED procedure enables physicians for the first time ever to use 3 clinically proven technologies on all 4 layers of the skin with a single system.

Pollogen Ltd., a global leader in medical aesthetics, will launch its latest development - the TriLipo MED procedure in Europe during the prestigious European Academy of Dermatology and Venerology Meeting (EADV) held in Lisbon, Portugal from October 20-24, 2012. The procedure is a breakthrough in aesthetic medicine since it allows practitioners for the first time to safely and effectively treat all four layers of the skin- the epidermis, dermis, hypodermis and muscle using a single system. By treating all four layers, practitioners can significantly improve and rejuvenate most facial and body areas. The anti-aging results are impressive- a significant reduction in wrinkles, lax skin, scars, cellulite and body circumference.

The TriLipo MED procedure is available using a single system, the Maximus platform, which can deliver three advanced proprietary technologies- TriLipo RF, TriLipo DMA and TriFractional. TriLipo radiofrequency (RF) is used to for skin tightening, cellulite reduction and fat reduction. The TriLipo dynamic muscle activation (DMA) is used on the body to clear released fat and on the face to “lift” the SMAS (Superficial Muscular Aponeurotic System). The TriFractional technology enables effective fractional skin resurfacing used on delicate areas such as the face, neck and décolleté. Combined, the technologies complement each other to provide enhanced anti-aging results.

During the EADV meeting, Gabriel Buendía, M.D., from the world rewound Médico Teknon Center in Barcelona, Spain will lecture on “Non invasive optical measurements of the skin for efficacy assessment of a radiofrequency system combined with dynamic muscle activation (DMA) for cellulite treatment: A comparative study” (Friday, October 21st at 10:10). The 10 week randomized study included 28 patients and confirmed the safety and efficacy of Pollogen’s TriLipo RF and TriLipo DMA technologies for cellulite reduction and circumference reduction on the thighs. The results showed a reduction of up to 4.5 cm in treated vs. untreated thighs. There were no adverse events. Results were validated using optical measurements which enabled extensive and precise assessments of the treatment outcomes and which confirmed texture and firmness improvement. The 3D optical analysis showed a pattern of improvement of dimples, nodules, firmness and volume for the treated thigh. In addition, high frequency ultrasound measurements used during the study demonstrated dermis thickening as well as a reduction of hypodermis thickness in the treated thigh.

Gabriel Buendía, M.D., stated: “The Medico Teknon Center is an advanced aesthetic clinic. It is important for us to use cutting edge technologies in order to deliver the best anti-aging results for our patients. I am very pleased with the study results and impressed by the TriLipo MED procedure”.

Pollogen will host a Meet the Expert Session on Saturday, October 22nd from 14:30-15:30. During the session Gabriel Buendía, M.D., will lecture on “TriLipo MED Body Treatments” and discuss the safety and efficacy of the TriLipo procedure in treating a wide variety of aesthetic needs- body contouring, cellulite reduction and skin tightening. In addition, A. Levenberg, M.D., an Israeli plastic surgeon who has been using Pollogen’s technology for over 6 years, will lecture on “TriLipo MED Facial Treatments”. Dr. Levenberg has been using the TriLipo MED procedure both post-liposuction and facelifts and as a stand-alone anti-aging solution. In his talk, Dr. Levenberg will present case studies which confirm the effective short and long term results achieved using the Maximus system.

Alexander Levenberg, M.D., said: “I am very excited about the TriLipo MED procedure. I have used it for a wide variety of treatments and I have seen impressive results. With no downtime, I am able to quickly and effectively treat delicate areas such as wrinkles around the lips and eyes, and post-liposuction the procedure enhances the results and accelerates the recuperation period”.

Amichai-Bar Nir, Company CEO stated: “Pollogen is dedicated to delivering innovation. The TriLipo MED procedure is an inclusive solution that provides a great deal of treatment flexibility. Physicians can use 3 technologies on 4 layers of skin tissue with a single system. We are excited about the TriLipo MED procedure and confident that it will quickly become the industry standard. “

About Pollogen
Pollogen Ltd. Is a global leader in the medical aesthetic market providing innovative, safe and effective solutions for women and men that enhance and expand the practice of medical aesthetic professionals. The company offers products to address a range of skin treatments under the industry’s three premier brands: TriPollar®, TriLipo® and TriFractional™.

Pollogen offers a full line of clinically-proven, non-invasive anti-aging facial and body contouring treatment platforms for circumference reduction, cellulite reduction and skin tightening. The company’s medical aesthetic devices, Maximus, apollo, and regen XL offer customers clinically-proven, safe and effective anti-aging lunchtime beauty treatments that deliver immediate and long-lasting results, With a distribution network in over 60 countries, Pollogen is providing innovative solutions to medical professionals globally.


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Ann Berzak

Sigal Katz Gradsztajn
Visit website